Axa cut its holdings in Owens & Minor, Inc. (NYSE:OMI) by 63.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,100 shares of the company’s stock after selling 32,600 shares during the period. Axa’s holdings in Owens & Minor were worth $316,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new position in Owens & Minor during the second quarter worth $170,000. Summit X LLC acquired a new position in Owens & Minor during the second quarter worth $181,000. NumerixS Investment Technologies Inc lifted its stake in Owens & Minor by 74.6% during the second quarter. NumerixS Investment Technologies Inc now owns 11,000 shares of the company’s stock worth $189,000 after purchasing an additional 4,700 shares in the last quarter. Glen Harbor Capital Management LLC lifted its stake in Owens & Minor by 47.4% during the second quarter. Glen Harbor Capital Management LLC now owns 11,928 shares of the company’s stock worth $199,000 after purchasing an additional 3,836 shares in the last quarter. Finally, Guyasuta Investment Advisors Inc. acquired a new position in Owens & Minor during the second quarter worth $206,000. Hedge funds and other institutional investors own 88.94% of the company’s stock.
A number of research analysts have commented on OMI shares. Barclays restated an “underweight” rating and set a $8.00 price target (down from $12.00) on shares of Owens & Minor in a research note on Thursday, November 1st. Leerink Swann set a $9.00 price target on Owens & Minor and gave the stock a “hold” rating in a research note on Wednesday, October 31st. Bank of America cut Owens & Minor from a “buy” rating to a “neutral” rating in a research note on Wednesday, October 31st. Finally, Jefferies Financial Group restated a “hold” rating and set a $8.50 price target on shares of Owens & Minor in a research note on Friday, November 2nd. Four equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. Owens & Minor presently has a consensus rating of “Sell” and an average price target of $12.90.
Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $0.32 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.32. The business had revenue of $2.46 billion for the quarter, compared to analysts’ expectations of $2.54 billion. Owens & Minor had a positive return on equity of 9.50% and a negative net margin of 1.57%. The company’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period last year, the firm earned $0.40 earnings per share. As a group, analysts anticipate that Owens & Minor, Inc. will post 1.22 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 2nd. Stockholders of record on Monday, December 17th will be paid a $0.075 dividend. This represents a $0.30 annualized dividend and a dividend yield of 4.31%. The ex-dividend date of this dividend is Friday, December 14th. Owens & Minor’s payout ratio is currently 64.60%.
TRADEMARK VIOLATION NOTICE: “Owens & Minor, Inc. (OMI) Position Reduced by Axa” was originally published by WKRB News and is owned by of WKRB News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.wkrb13.com/2018/12/10/owens-minor-inc-omi-position-reduced-by-axa.html.
Owens & Minor Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. It operates through three segments: Domestic, International, and Proprietary Products. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices.
Further Reading: Asset Allocation, Balancing Your Investments
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.